X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 2 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding X4 Pharmaceuticals, Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 84 | 89 | +5 |
| Shares | 93.9M | 99.2M | +5.25M (+5.6%) |
| Value | $388.1M | $463.0M | +$75.0M (+19.3%) |
New holders (32)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (27)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q1 2026 and filed for Q2 2026 without it.